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Background: Cost-of-illness analysis is the main method of providing an overall vision of the economic impact of a
disease. Such studies have been used to set priorities for healthcare policies and inform resource allocation. The
aim of this study was to determine the economic burden and health-related quality of life (HRQOL) in the first,
second and third years after surviving a stroke in the Canary Islands, Spain.
Methods: Cross-sectional, retrospective study of 448 patients with stroke based on ICD 9 discharge codes, who
received outpatient care at five hospitals. The study was approved by the Research Ethics Committee of Nuestra
Señora de la Candelaria University Hospital. Data on demographic characteristics, health resource utilization,
informal care, labor productivity losses and HRQOL were collected from the hospital admissions databases and
questionnaires completed by stroke patients or their caregivers. Labor productivity losses were calculated from
physical units and converted into monetary units with a human capital-based method. HRQOL was measured with
the EuroQol EQ-5D questionnaire. Healthcare costs, productivity losses and informal care costs were analyzed with
log-normal, probit and ordered probit multivariate models.
Results: The average cost for each stroke survivor was €17 618 in the first, €14 453 in the second and €12 924 in
the third year after the stroke; the reference year for unit prices was 2004. The largest expenditures in the first year
were informal care and hospitalizations; in the second and third years the main costs were for informal care,
productivity losses and medication. Mean EQ-5D index scores for stroke survivors were 0.50 for the first, 0.47 for the
second and 0.46 for the third year, and mean EQ-5D visual analog scale scores were 56, 52 and 55, respectively.
Conclusions: The main strengths of this study lie in our bottom-up-approach to costing, and in the evaluation of
stroke survivors from a broad perspective (societal costs) in the first, second and third years after surviving the
stroke. This type of analysis is rare in the Spanish context. We conclude that stroke incurs considerable societal costs
among survivors to three years and there is substantial deterioration in HRQOL.
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Stroke is the second leading cause of death after ische-
mic heart disease (IHD), and the third leading cause of
disability-adjusted life years in high-income countries
after IHD and unipolar depressive disorders [1]. Up to
16% of patients die within the first month after their
stroke [2,3], and within 1 year after the stroke event
nearly 55% die or experience severe consequences [4].
About one half of survivors are left with permanent dis-
abilities and have significant needs for rehabilitation and
long-term care [5].
Apart from large costs for home- and hospital-based
rehabilitation and care, there are also other societal costs
related to stroke, such as direct non-healthcare costs
(formal and informal care) and productivity losses. Aging
of the population may further increase demands on the
healthcare system due to stroke in the future [6], which
makes stroke-related costs an important area of study.
Previous studies have assessed the impact of stroke on
health-related quality of life (HRQOL) with the EuroQol
EQ-5D questionnaire [7-13]. The main findings suggest
that stroke survivors have significantly impaired
HRQOL, and that the burden of nonfatal stroke should
thus be recognized more widely. Measures of HRQOL
yield information that is not provided by traditional out-
come scores; accordingly, some studies support guide-
lines to measure HRQOL in stroke research [8].
Traditionally, health has been evaluated objectively
based on observation or medical interventions, and tak-
ing into account general indicators such as life expect-
ancy, mortality and disease prevalence. However, these
indicators have lost part of their predictive value in
wealthy societies where diseases tend to be chronic, mor-
tality rates are extremely low and life expectancies have
reached new heights. This scenario calls for concepts and
measures of health that are more dynamic, and a strictly
biomedical model is being replaced by one that includes
patients’ assessments of their own heath [14,15].
The Canary Islands Health Service considers that in-
formation on HRQOL, together with other information
sources such as epidemiological and socioeconomic in-
formation, plays a key role in priority-setting and re-
source allocation among different health problems in
healthcare planning [16]. In recent decades HRQOL has
increased in importance as a key health status indicator.
In the Canary Islands, with a population close to 2
million, the demographic structure, aging rate, health
expectations and infant mortality are similar to the mean
values for all of Spain [17]. The National Health System
in each of Spain’s 17 regions guarantees free access and
universal coverage, as well as an identical healthcare
package for every citizen [18]. Furthermore, ratios of
healthcare resources (professionals, structural and
technological equipment) in the Canary Islands are inline with average values in Spain [19]. Therefore, there is
no reason to assume that the cost of resources in our
study differs substantially from elsewhere in Spain. This
study was designed to examine stroke costs using differ-
ent approaches. First, we analyzed the societal costs in-
curred by patients during their first, second and third
year after surviving a stroke event. Second, we analyzed
their HRQOL in the first, second and third years after
the stroke. Finally, we identified associations between
HRQOL and societal costs.
Methods
Research design and subjects
This was a cross-sectional, retrospective study of people
diagnosed with stroke who received outpatient care and
were living in the community. Patients were recruited
from five hospitals in the Canary Islands, Spain. All
patients with stroke were admitted to the hospital. They
were not initially seen by a general practitioner.
The patients were divided into three categories: 1-, 2-
and 3-year survivors after stroke (group 1, group 2 and
group 3, respectively). All patients and caregivers were
informed about the study objectives and data confidenti-
ality, and were asked to indicate their understanding of
the study conditions and agreement to participate by
signing an informed consent form. The study was
approved by the Research Ethics Committee of Nuestra
Señora de la Candelaria University Hospital.
Information and variables of interest
The fieldwork was carried out between January and
December 2004. The questionnaires were adminis-
tered by postal survey. The information sources used
in the study were the hospital admissions database
and a self-completed questionnaire completed by
patients or their caregivers [20-22]. Demographic and
clinical data were collected from patients diagnosed
previously with stroke and caregivers.
To estimate resource utilization, the questionnaire
solicited information covering the 6-month period prior
to the study (12 months for hospital admissions). Data
for the preceding 6 months were extrapolated to the en-
tire year. We considered 6 months to be an appropriate
recall period [21,22]. Information on hospital admissions
was obtained from hospital databases. Patients or their
caregivers were asked about reductions in working time
and any temporary and permanent disability, and these
data were used to calculate losses of labor productivity.
Information about HRQOL was collected from survivors
with the generic EQ-5D questionnaire [23].
Costing methodology
We used the prevalence approach to estimate costs. Dis-
ease prevalence takes into account all existing cases
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tion, treatment and rehabilitation, plus losses as a result
of morbidity and mortality within that year. Prevalence-
based cost-of-illness analysis has the advantage of
incorporating measurements of total annual healthcare
expenditure, which is particularly relevant for chronic
conditions such as stroke that require long-term treat-
ment [20-22]. In this context, a bottom-up costing ap-
proach was used to estimate total and average annual
costs [24].
Data on resources were collected for each patient. The
resources used were multiplied by unit costs to estimate
the annual cost per patient, with 2004 as the reference
year. A societal perspective was also used in the study.
Two types of direct costs were considered: those derived
from healthcare and non-healthcare costs (formal and
informal care). Labor productivity losses were estimated
from physical units converted into monetary units with
an approach based on human capital theory [25].
Direct healthcare costs
Direct costs were derived from healthcare utilization.
The value of resources used by patients was calculated
in terms of the relevant unit costs and the average cost
per patient in the sample. Information about the number
of hospital admissions was obtained from the admissions
databases of each of five hospitals in the Canary Islands
Health Service. Inpatient care was based on diagnosis-
related group (DRG) costs. Unit costs were estimated
with a microcosting method (not charges for reimburse-
ment) for DRGs (unit costs published by the Spanish
Ministry of Health) based on the average cost per DRG
from 18 hospitals in Spain (including one hospital from
the Canary Islands) [26].
Data for the volume of outpatient care (rehabilitation,
medical tests and examinations, visits to health profes-
sionals and home medical care) and the number of
emergency visits were obtained from the questionnaires.
The unit cost was obtained from the SOIKOS healthcare
cost database [27], then multiplied by the resource quan-
tities. SOIKOS is the most complete database used in
Spain to obtain healthcare unit costs. The sources of
unit costs were published articles, reports, hospital
accounting systems, etc.; the figures are updated every
year.
Information regarding the medications consumed by
patients with stroke was obtained from the question-
naires. The cost of drugs used by patients was calculated
by determining the daily cost for each of the products
used (based on the cost of each package dispensed and
the dose used), and was then multiplied by duration of
use. When no information concerning the number of
units per package was available, we assumed the largest
dispensation package for drugs. The costs of prescriptiondrugs used were obtained from the list of approved
drugs in Spain [28].
Information concerning the use of orthopedic devices
and healthcare-related transportation was obtained from
the questionnaires. The costs of orthopedic devices were
obtained from the SOIKOS healthcare unit cost database
[27], distribution firms, the Canary Islands regional le-
gislative record and the Spanish parliamentary record.
Direct non-healthcare costs
Informal care is defined as the performance of tasks by
nonprofessionals that help maintain or enhance patient
independence. Therefore, informal services are defined
as the group of tasks or care provided by nonprofes-
sional caregivers, who are often relatives but may also be
friends or neighbors. Information about informal care
was obtained from the questionnaires, specifically from
the items concerning the time spent helping the patient
with his or her basic daily activities, and the time spent
helping with necessary instrumental daily activities.
To estimate time used to provide care to patients, we
used the opportunity cost of the time spent by the infor-
mal caregiver, which in economic terms is equal to the
wage the caregiver would have earned if an alternative
paid activity had been performed [29]. For the main and
secondary caregiver, this method assigns a cost per hour
based on the gross wage for a domestic cleaner.
Information on formal care provided by social services
and professional caregivers was obtained from the
questionnaires.
Loss of labor productivity
Data on loss of labor productivity were obtained from
physical units converted into monetary units with a
human capital-based approach [25]. Gross wages before
the deduction of taxes and social security contributions
are considered a good proxy for labor productivity
losses. According to human capital theory [25], the aver-
age earnings (wage) of a worker are considered a reason-
able measure of labor productivity, and can be used as
the basis for estimating future wages that go unearned if
a worker leaves the labor market as a result of an illness
or accident. Labor productivity is described in terms of a
worker’s remuneration in the labor market. Thus, our
calculations were based on average gross wage figures in
the 2004 Wage Structure Survey of the Spanish National
Statistics Institute [30]. Annual losses of labor productiv-
ity were estimated for the year 2004.
Patient outcomes
The EQ-5D is a simple generic instrument developed by
a multidisciplinary group of researchers [23]. This ques-
tionnaire has been validated in Spain and is commonly
used in economic evaluation and technology assessment.
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regions of Spain – Catalonia and the Canary Islands –
where the populations are similar [31].
There are five dimensions in the EQ-5D covering
the areas of mobility, self care, everyday activities,
pain/discomfort and anxiety/depression. A total of
243 possible health states can be defined in this way.
Evaluations of these health states have been reported
for the general population [32]. The values or utilities
are indicated on a scale on which 0 is the value of
death and 1 is the value of perfect health. For statis-
tical analysis, the scores on the EQ-5D were divided
into four categories of HRQOL: very poor (EQ-5D
index scores less than 0), poor (EQ-5D index scores
between 0 and 0.5), fair (EQ-5D index scores between
0.51 and 0.85) and good (EQ-5D index scores higher
than 0.85). The main reason is that although the set
of social values in the EQ-5D is apparently a continu-
ous variable, gaps or discontinuities in the distribu-
tion of scores may make it more informative to
interpret the findings as a categorical variable for the
purposes of fitting statistical models and interpreting
the results.
Statistical models
Because of the different distributions of the main items, dif-
ferent estimation methods were chosen. Healthcare costs
were analyzed with a log-normal multivariate model. Prod-
uctivity losses were analyzed with a probit model, a type of
discrete response model in which the variable of interest is
a binary variable that takes a value of 0 if there is no prod-
uctivity loss, and a value of 1 if there is productivity loss.
Because of the high percentage of the sample who were
past the legal retirement age (65 years), the analysis wasTable 1 Characteristics of the sample and population
Interview sample Total (n=448




Is there a main caregiver?
Yes 62.9%
No 37.1%
Is there a second caregiver?
Yes 32.59%
No 67.41%
Informal care hours per week (whole sample) 35.0 (35.3)
Informal care hours per week at least one caregiver) 55.1 (29.2)
Health-related quality of life (EQ-5D VAS) 53.69 (26.29)
Health-related quality of life (EQ-5D index score) 0.4708 (0.4388
Expressed as mean or percentage (Standard deviation in parentheses).done initially with the whole sample, and then only with
people under 65 years of age. To analyze informal care
costs, an ordinate probit model was used in which the
dependent variable takes a value of 0 if the person received
no informal care, a value of 1 if the person received less
than 60 hours per week, and a value of 2 if more than
60 hours of informal care were received per week.
The aim of the models was to determine whether
HRQOL was significantly related to the number of years
elapsed since the stroke, with age and sex as control
variables. To this end we used an ordinary least squares
model (robust for heteroscedasticity) for the effects of
healthcare costs, a probit model to identify the likeli-
hood of job losses, and an ordered probit model to
analyze the effects of the amount of informal care
received.
Results
A total of 480 questionnaires were collected (34% of all
questionnaires sent) from people with stroke, 32 of
which were excluded because the information they con-
tained was insufficient or inadequate. There was no dif-
ference in sex or age distribution between patients who
responded to the questionnaire and those who did not.
The main characteristics of our sample are shown in
Table 1. The estimated average cost per person was €17
618 after 1 year of survival, €14 453 after 2 years and
€12 924 after 3 years (Table 2). Informal care costs made
up the largest proportion, at 60% of the total average per
person cost after 1 year of survival, 77% after 2 years
and 76% after 3 years. Healthcare expenditures ranged
between 28% of the total expenditure for 1-year survi-
vors and 15% for 2-year and 3- year survivors. The cost
of productivity losses was less than informal care and) Group 1 (n=94) Group 2 (n=205) Group 3 (n=149)







34.8 (34.6) 36.9 (34.7) 32.5 (36.6)
52.8 (29.5) 54.9 (28.4) 57.0 (30.7)
55.96 (26.62) 51.64 (27.04) 55.03 (24.98)
) 0.4961 (0.4246) 0.4674 (0.4407) 0.4596 (0.4475)
Table 2 Annual average costs of stroke survivors after 1, 2 and 3 years in Canary Islands, Spain
1year (n=94) 2years (n=205) 3years (n=149)
Direct healthcare costs (in €)
Acute hospitalization 2,827 (879) 63 (660) 14 (171)
Rehabilitation 462 (903) 472 (935) 274 (748)
Drugs 752 (660) 635 (649) 773 (813)
Tests 283 (535) 510 (1 576) 332 (540)
Emergency department care (acute) 91 (261) 90 (187) 93 (380)
Outpatient and primary healthcare visits 149 (301) 99 (179) 152 (230)
Medical home care 17 (67) 18 (65) 13 (45)
Orthopedic devices 105 (179) 99 (178) 77 (156)
Healthcare transportation 321 (816) 185 (478) 164 (453)
Subtotal 5007 (2 238) 2173 (2 430) 1894 (1 652)
Direct non-healthcare costs (€)
Caregiver’s time costs (informal care) 10 523 (10 440) 11 158 (10 495) 9828 (11 050)
Social services 161 (612) 127 (677) 228 (853)
Subtotal 10 684 (10 575) 11 285 (10 572) 10 057 (11 336)
Total, Direct costs 15 691 (11 464) 13 457 (11 374) 11 951 (11 879)
Loss of labor productivity (in €)
Subtotal 1926 (4616) 995 (3396) 973 (3522)
Total costs 17 618 (12 633) 14 453 (11 914) 12 924 (12 314)
Expressed as mean (Standard deviation in parentheses).
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the high average age of the participants, most of whom
had left the labor market at the moment of their stroke.
Two thirds (65%) of the participants were more than
65 years old, the legal retirement age in Spain.
With regard to the HRQOL of people who have sur-
vived a stroke, the EQ-5D index score was 0.47 over 1,
and the EQ-5D VAS score was 53.69 over 100 (Table 1).
These scores are significantly lower than in the general
population, after controlling for age and for other
chronic diseases [33]. Also of note is that the HRQOL
was similar in 1-, 2- and 3-year survivors. This indicates
that after a stroke, some survivors will recover but
others will suffer permanent sequelae, which means that
personal autonomy will be limited (dependence) and
their HRQOL will remain low.
Table 3 shows the results of the statistic analyses of
costs related to the main explanatory variables. Time
since the stroke event and HRQOL were explanatory
variables, whereas age, age squared and sex were used as
control variables. Informal care, healthcare costs and
productivity losses were analyzed separately because of
differences in their characteristics and distribution. For-
mal care at home (part of non-healthcare direct costs)
was not included because it accounted for only a small
proportion of the overall cost.
The variables age, time of the stroke event and
HRQOL significantly affected healthcare costs. The
age–cost curve was concave, and was greatest at age55 years. Sex did not affect healthcare costs, whereas
the effect of stroke event was significant. The reason is
that healthcare costs during the first year are strongly
conditioned by the initial hospitalization. In marginal
terms and after controlling for the other variables,
health expenditures were on average €2900 less for 2-
year survivors, and €3200 less for 3-year survivors, with
differences in hospital expenditures accounting for most
of the decrease with time. The influence of HRQOL on
costs was reflected in our findings: a poor HRQOL was
significantly associated with greater healthcare expend-
iture. For example, expenditures for patients with an
HRQOL score less than 0 (very poor HRQOL) were
more than €2000 greater than in patients with a better
HRQOL.
Age, sex, time of stroke event and HRQOL were sig-
nificantly related to the likelihood of positive productiv-
ity losses. When men under 65 years of age were used as
the reference group, women were 31% less likely than
men to experience productivity losses. However, this re-
sult should be regarded with caution because the pro-
portion of women in the Spanish labor market is much
lower than the proportion of men. Therefore, the likeli-
hood of temporary or permanent loss from the labor
market is expected to be larger in men, since this group
made up the larger proportion of wage-earners before
the stroke event. Age, sex and years of survival were not
significantly related to the quantity of informal care
received. In contrast, HRQOL was a significant variable.
Table 3 Statistical analysis of healthcare costs, productivity losses and informal care costs
Log healthcare
costs
Loss of labor productivity,
probit model marginal effects
Informal costs, ordered probit model marginal effects









Age 0.055 ** (0.026) 0.0298** (0.011) 0.177** (0.077) 0.0105 (0.012) 0.0003 (0.0007) −0.011 (0.012)
Age-squared −0.0005** (0.0002) −0.0003** (0.0001) −0.0017 **(0.0007) −0.0001 (0.0001) −0.00002 (0.000001) 0.0001 (0.0001)
Female −0.131 (0.104) −0.062** (0.029) −0.309 ** (0.0703) 0.028 (0.040) 0.0007 (0.0017) −0.029 (0.0412)
Patient Group 2¥ −1.306** (0.095) −0.088** (0.035) −0.223 ** (0.087) −0.0002 (0.0515) −0.00001 (0.0017) 0.0002 (0.0531)
Patient Group 3¥¥ −1.446** (0.114) −0.085** (0.0314) −0.237 **(0.082) −0.0402 (0.0545) −0.0021 (0.0044) 0.0422 (0.0566)
HRQOL Fair 0.436** (0.146) (0.020) (0.043) 0.0095 (0.103) 0.181** (0.0535) −0.004 (0.010) −0.176** (0.050)
HRQOL Poor 0.875** (0.165) 0.131** (0.069) 0.343** (0.126) 0.275** (0.068) −0.0467* (0.0257) −0.229** (0.048)
HRQOL Very poor 1.201** (0.151) 0.282** (0.081) 0.319** (0.149) 0.526** (0.058) −0.145** (0.041) −0.382** (0.039)
Sample 424 424 154 423 129 155 139
F (8,415) 38.88 78.02 40.97 76.48
R-squared 0.3179 0.2090 0.2135 0.0823
Reference category: men, patient group 1, HRQOL good.
Standard deviation between brackets.
** Statistically significant at 95% confidence level.
* Statistically significant at 90% confidence level.
¥ 2-year survivors.
¥¥ 3-year survivors.
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receiving more than 60 hours of informal care. Com-
pared to participants with a good HRQOL, people with
a very poor, poor or fair HRQOL were 53%, 28% and
18% more likely, respectively, to have received more
than 60 hours/week informal care. The same reasoning
was used to analyze the marginal effects of HRQOL
without informal care. People in the very poor HRQOL
category were 38% less likely to receive informal care
than a person with good HRQOL.
Discussion
In recent decades, stroke has been a major health-
related problem with important social consequences in
high-income countries. The high incidence and preva-
lence of stroke and its social consequences in terms of
mortality, morbidity and economic costs justify the at-
tention this diagnosis has received from health author-
ities and society in general.
A variety of international studies have analyzed stroke-
related costs [34-45]. There is general agreement that
total direct healthcare expenditure on stroke in high-
income countries accounts for 3% to 6% of all national
health service expenditure [36,37,39-42]. During the first
year after the stroke event, in-patient expenditure repre-
sents about 75% of total healthcare costs [45,46]. How-
ever, in comparison to other neurodegenerative diseases
such as Alzheimer’s disease, the inclusion of societal
costs is a recent phenomenon in cost-of-illness studies
of stroke. Nevertheless, informal care for stroke patients
may be a significant hidden cost to society [47-49].The present analysis highlights the importance of
studying the economic consequences of stroke and inter-
preting the results in an international context. Although
the ideal design for bottom-up studies of the societal
costs of stroke is a population-based cohort study, the
results of our analysis provide insights into the distribu-
tion of the costs of stroke and the impact of stroke on
national expenditures for healthcare.
We show that in 2004, the estimated annual cost per
stroke survivor was €17 618 for the first year, €14 453
for the second year and €12 924 for the third year. By
analyzing healthcare and non-healthcare costs separ-
ately, we found that informal care costs increased in
relative terms during the years following the stroke. The
composition of healthcare costs evolved during the
3 years after the stroke. During the first year, informal
care and hospitalization costs were the largest expendi-
tures. However, for 2-year and 3-year survivors, the lar-
gest costs were for informal care, productivity losses,
drugs and rehabilitation.
The high cost of informal care in this study may have
several possible explanations. First, the methodology we
used may have influenced our estimates. In earlier stud-
ies, indirect costs included costs related to both job loss
and informal care. Cost-of-illness studies published more
recently, however, use more precise classifications of the
items that contribute to societal costs. Second, because
of our study design, people in institutions were excluded
from the analysis. Moreover, in Spain, home-based social
services are limited compared to other countries in cen-
tral and northern Europe [50-52]. Therefore, the main
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consequently informal care costs are very high.
The present study quantifies the activity of informal
caregivers, and also highlights the importance of infor-
mal care. Informal stroke care represents a significant
hidden cost to Spanish society. Because the Spanish
population is aging rapidly, the formal and informal care
burden may increase significantly in the future. The
present study also shows that non-medical home care
(private transport and social services) represents only 5%
of direct non-healthcare costs. However, social changes
(incorporation of women into the labor market, smaller
family size, greater social demand for professional care)
point to a growth in the need for formal care in the
coming years.
Productivity losses were greatest in first-year survivors,
a finding that may reflect the return to the labor market
of second- and third-year survivors.
HRQOL is another source of information that helps
to define the global impact on society of a specific
health problem; is also useful to set priorities and allo-
cate resources, together with other information sources
such as incidence, prevalence, mortality and costs.
Knowledge of HRQOL is also needed to measure the ef-
fectiveness of health interventions on disease manage-
ment. Despite the relative frequency of stroke, this
diagnosis is characterized by a substantial economic and
HRQOL burden. Stroke survivors with poor or very
poor HRQOL are more likely to have positive product-
ivity losses compared to people with fair and good
HRQOL. In the sample we studied, poor or very poor
HRQOL was related with a 30% greater likelihood of
productivity losses.
Multivariate analysis showed that the average cost per
patient was significantly lower in 2- and 3-year survivors
compared to 1-year survivors. The high cost of hospital
services during the first year of survival probably
accounts for this finding.
Limitations
Further, our estimates for survivors of stroke may be
overestimated since there was no adjustment for pre-
stroke costs and co-morbidity. This may be reflected
more strongly in the 2nd and 3rd year costs [53].
Our choice of variables and the econometric model
were restricted by the explanatory variables available in
the database. Age and sex were the only socioeconomic
variables included in the patient survey. Another limita-
tion of our study was that we had no information
regarding clinical evidence of event severity. We would
expect that more severe events in survivors would be
predictive of higher costs. HRQOL and time elapsed
since the stroke (1, 2 or 3 years) were used as proxy vari-
ables to measure the degree of severity. These variablesexplained not only direct costs but also informal care
costs. Although our choice of survival times may have
been too broad, the use of a greater number of time
intervals is not recommended since this would impose
limits on the sample size.
Several other limitations deserve mention. The most
important is the use of cross-sectional data from a study
done in the Canary Islands (Spain), which may limit the
generalizability of our conclusions. However, the five
participating hospitals in the Canary Islands were
selected to reflect potential differences in diagnostic and
therapeutic patterns. Furthermore, the ratios of profes-
sional, structural and technological healthcare resources
in the Canary Islands are in line with average values in
Spain [19]. Therefore, there is no reason to assume that
the cost of the resources consumed by the regional cen-
ters we studied differs substantially from costs elsewhere
in Spain.
Another major limitation of this study is the fact that
the costs of institutionalization and long-term care were
not included. Although nursing home availability in
Spain is increasing, actual use remains quite low, forcing
most potential residents to receive home care. Another
limitation is potential recall bias, given that patient-
based data were obtained by questionnaire.
The retrospective analysis used in the present study
entails a risk of bias in sample selection. The findings
may thus have been influenced by our lack of informa-
tion about the characteristics of patients who died dur-
ing the second and third year after their stroke.
Despite the limitations of cost-of-illness analysis stud-
ies, the governments of many countries and regions con-
tinue to encourage researchers to carry them out. The
reason is that decision-makers consider information
about the financial impact of diseases to be a useful in-
put for program planning [54]. This information does
not replace, but rather complements, epidemiological in-
formation on population-level health problems.
The Spanish Ministry of Health and Social Policy has
included estimates of the associated costs of stroke in a
recent policy document titled Strategies for Stroke in the
National Health System, in order to document the social
significance of this health problem with a view to pro-
posing measures for stroke prevention and care [55].
This growing level of interest suggests that the ability of
cost-of-illness analysis to help us understand the social
impact of diseases may allow this approach to become a
useful tool for designing public policies [55,56].
In spite of these limitations, we believe that this study
represents the most complete and realistic costing to
date of the burden of stroke in the Canary Islands and
Spain. The main strength of the study lies in the
bottom-up approach to costing. In addition, the costs
were estimated for a period of 3 years rather than 1 year,
Lopez-Bastida et al. BMC Health Services Research 2012, 12:315 Page 8 of 9
http://www.biomedcentral.com/1472-6963/12/315thus our estimated costs provide a more accurate picture
of the medium-term burden of stroke.
Two previous studies have analyzed healthcare costs
in terms of labor productivity losses and informal care
costs related to stroke in Spain [57,58]. One study has
examined the costs of formal and informal care (non-
healthcare costs) together with HRQOL [59]. However,
ours is the first study to consider societal costs and
HRQOL associated with surviving a stroke event in
Spain. We found that most of the societal cost is repre-
sented by informal care. Additionally, we show that
worse HRQOL is associated with greater social costs of
stroke.
A clear understanding is needed of the current pat-
terns of resource use, costs, and HRQOL in stroke survi-
vors in order to inform health services planning
appropriately. Cost-of-illness studies need to be updated
to understand the economics of diseases and their chan-
ging cost structures. This will enable policymakers to
achieve a better understanding of the factors that have
an impact on stroke-related expenditures, and will also
enable a better-informed distribution of resources.Conclusions
Stroke incurs considerable societal costs even in survi-
vors, including very high economic costs and a deterior-
ation in health-related quality of life. Informal stroke
care represents a significant hidden cost to Spanish soci-
ety. Because the Spanish population is aging rapidly, the
burden of formal and informal care may increase signifi-
cantly in the future.
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